Sentences with phrase «improved lung cancer patient»

Recent findings suggest a novel positron emission tomography (PET) imaging approach determining epidermal growth factor receptor (EGFR) mutation status for improved lung cancer patient management.

Not exact matches

April 16 Merck & Co's immunotherapy Keytruda plus chemotherapy significantly improved overall survival versus chemotherapy alone in newly - diagnosed patients with advanced non-small cell lung cancer in a highly - anticipated study that appears to cement the company's lead in the most lucrative oncology market.
Patients aged 65 years and older are living longer after lung cancer surgery, and with older people representing a rapidly growing proportion of patients diagnosed with lung cancer, this improved survival is especially significant, according to an article posted online today by The Annals of Thoracic SPatients aged 65 years and older are living longer after lung cancer surgery, and with older people representing a rapidly growing proportion of patients diagnosed with lung cancer, this improved survival is especially significant, according to an article posted online today by The Annals of Thoracic Spatients diagnosed with lung cancer, this improved survival is especially significant, according to an article posted online today by The Annals of Thoracic Surgery..
«FDG PET shows tumor DNA levels in blood are linked to NSCLC aggressiveness: Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer
Ceritinib significantly improved patient - reported outcomes including lung cancer - specific symptoms and overall health status, compared to placebo (p < 0.05).
Principal Investigator John Morris, MD, clinical co-leader of the Molecular Therapeutics and Diagnosis Program for the CCC, co-leader of the UC Cancer Institute's Comprehensive Lung Cancer Program, professor in the division of hematology oncology at the UC College of Medicine and UC Health medical oncologist, says a number of antitumor vaccines have shown promise for causing immune responses against tumor antigens to improve patient outcomes.
«First - line immunotherapy treatment can improve survival for subset of lung cancer patients: Results of phase III global clinical trial show that 75 percent of stage IV lung cancer patients with both complex tumor mutations and PDL - 1 positive status respond to nivolumab.»
If we are able to refine a test to diagnose lung cancer by measuring breath temperature, we will improve the diagnostic process by providing patients with a stress - free and simple test that is also cheaper and less intensive for clinicians.»
Testing for the EGFR mutation and ALK rearrangements and the use of targeted therapies have given lung cancer patients the chance for survival, along with improved quality of life and time with loved ones.
The same benefits of increased activity observed in lung cancer patients, especially improved symptoms and quality of life, appear to apply to lung cancer survivors as well.
If this is true, then immunocheckpoint blockade combination with EGFR tyrosine kinase inhibitors is a major path towards improving outcome of patients who have EGFR - mutant non-small-cell lung cancer
Clinical trials found that it is safe to regularly infuse brain and lung cancer patients with 800 — 1000 times the daily recommended amount of vitamin C as a potential strategy to improve outcomes of standard cancer treatments.
«Programs that provide treatment for lung cancer also must measure their performance actively and carefully in order to improve the quality of care and improve patients» chances of survival.»
«This is the first study to show that this visit can improve a patient's understanding of lung cancer screening, allowing them to make a decision about participation that fits their values,» noted Dr. Mazzone.
DENVER — Elderly patients with stage III non-small cell lung cancer (NSCLC) showed improved overall survival (OS) when treated with chemoradiation (CRT) compared to definitive radiation (RT) alone.
Patients, especially those with larger tumors, who undergo thoracoscopic resections might have improved cancer specific survival compared with those undergoing SABR for early stage non-small lung cancer
Joint evidence - based guideline to improve care for patients with non-small cell lung cancer (NSCLC).
The risk of cardiovascular related illness and death is known to decrease after smoking cessation in patients with coronary heart disease, 40 reducing dramatically over the first three years, 41 but reducing the risk of developing lung cancer after smoking cessation generally takes longer.9 41 This review has found evidence that after lung cancer has been diagnosed, reductions in risk of developing a second primary or recurrence were associated with quitting within seven years, suggesting that, even at this stage, the prognostic outlook can be improved by smoking cessation.
Though it was already approved for melanoma, FDA regulators requested more detailed data from its latest trial to make certain that it will eventually improve survival rates among lung cancer patients.
A recent study published in the British Journal of Cancer suggests walking could improve the quality of sleep for lung cancer patCancer suggests walking could improve the quality of sleep for lung cancer patcancer patients.
Mary O'Brien, an oncologist at Royal Marsden Hospital in London, first stumbled upon these findings while inoculating lung cancer patients with a strain of M. vaccae (pronounced «emm vah - kay») to see if their symptoms improved.
Study: Walking could improve the sleep of lung cancer patients.
MBSR (supplementary to care - as - usual) has been shown to be effective in reducing stress levels and improving quality of life in patients with lung cancer (Schellekens et al., 2017).
a b c d e f g h i j k l m n o p q r s t u v w x y z